H.-H. Tai

1.1k total citations
30 papers, 916 citations indexed

About

H.-H. Tai is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, H.-H. Tai has authored 30 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in H.-H. Tai's work include Inflammatory mediators and NSAID effects (11 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Steroid Chemistry and Biochemistry (5 papers). H.-H. Tai is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Steroid Chemistry and Biochemistry (5 papers). H.-H. Tai collaborates with scholars based in United States, Canada and Netherlands. H.-H. Tai's co-authors include Mark Ensor, Charles J. Sih, Rong‐Fong Shen, J. R. G. Challis, R. Sangha, John C. Walton, Ichiro Fuse, Richard T. Okita, Y. Y. Tsong and Barry R. Rifkin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

H.-H. Tai

30 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.-H. Tai United States 20 393 315 137 129 121 30 916
Henry S. Edelson United States 14 261 0.7× 270 0.9× 64 0.5× 327 2.5× 59 0.5× 14 1.1k
I. J. Zeitlin United Kingdom 20 344 0.9× 246 0.8× 91 0.7× 111 0.9× 67 0.6× 65 1.3k
Min Tong United States 20 535 1.4× 810 2.6× 152 1.1× 122 0.9× 71 0.6× 35 1.5k
Robert McNish United States 16 399 1.0× 238 0.8× 160 1.2× 274 2.1× 41 0.3× 18 1.1k
Berit Sternby Sweden 24 603 1.5× 146 0.5× 121 0.9× 88 0.7× 132 1.1× 59 1.6k
M A Bayne United States 8 275 0.7× 337 1.1× 136 1.0× 46 0.4× 46 0.4× 11 782
B. Sorg Germany 19 577 1.5× 76 0.2× 80 0.6× 116 0.9× 47 0.4× 55 1.0k
Adriana Brondani da Rocha Brazil 24 705 1.8× 213 0.7× 27 0.2× 103 0.8× 148 1.2× 41 1.5k
I F Stamford United Kingdom 19 239 0.6× 804 2.6× 168 1.2× 68 0.5× 40 0.3× 43 1.3k
E. Highland United States 10 417 1.1× 175 0.6× 176 1.3× 238 1.8× 50 0.4× 12 998

Countries citing papers authored by H.-H. Tai

Since Specialization
Citations

This map shows the geographic impact of H.-H. Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.-H. Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.-H. Tai more than expected).

Fields of papers citing papers by H.-H. Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.-H. Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.-H. Tai. The network helps show where H.-H. Tai may publish in the future.

Co-authorship network of co-authors of H.-H. Tai

This figure shows the co-authorship network connecting the top 25 collaborators of H.-H. Tai. A scholar is included among the top collaborators of H.-H. Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.-H. Tai. H.-H. Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Tai, H.-H., et al.. (2002). Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. Prostaglandins Leukotrienes and Essential Fatty Acids. 67(6). 461–465. 37 indexed citations
4.
Tai, H.-H., et al.. (2002). Threonine 11 of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD+ during catalysis. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(5-6). 505–509. 9 indexed citations
5.
Patel, Falguni A., et al.. (2002). Differential Changes in 15-Hydroxyprostaglandin Dehydrogenase and Prostaglandin H Synthase (Types I and II) in Human Pregnant Myometrium. The Journal of Clinical Endocrinology & Metabolism. 87(3). 1345–1352. 40 indexed citations
6.
Zhou, Huiping, Fang Yan, & H.-H. Tai. (2001). Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases.. PubMed. 298(3). 1243–51. 26 indexed citations
7.
Tai, H.-H., et al.. (1999). Cyclic AMP response element mediates dexamethasone induced suppression of prostaglandin H synthase-2 gene expression in human amnion derived WISH cells. Prostaglandins Leukotrienes and Essential Fatty Acids. 60(4). 243–248. 10 indexed citations
8.
Tai, H.-H., et al.. (1998). Prostaglandin E2 receptor EP3α subtype: the role of N-glycosylation in ligand binding as revealed by site-directed mutagenesis. Prostaglandins Leukotrienes and Essential Fatty Acids. 59(4). 265–271. 12 indexed citations
10.
Slabaugh, Mary B., H.-H. Tai, Jan G. Jaworski, & Steven J. Knapp. (1995). cDNA Clones Encoding [beta]-Ketoacyl-Acyl Carrier Protein Synthase III from Cuphea wrightii. PLANT PHYSIOLOGY. 108(1). 443–444. 22 indexed citations
11.
Sangha, R., John C. Walton, Mark Ensor, H.-H. Tai, & J. R. G. Challis. (1994). Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor.. The Journal of Clinical Endocrinology & Metabolism. 78(4). 982–989. 116 indexed citations
12.
Chavan, Ashok J., Mark Ensor, Pan Wu, Boyd E. Haley, & H.-H. Tai. (1993). Photoaffinity labeling of human placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase with [alpha-32P]2N3NAD+. Identification of a peptide in the adenine ring binding domain. Journal of Biological Chemistry. 268(22). 16437–16442. 20 indexed citations
13.
Xia, Zhengyuan, Rong‐Fong Shen, Seung Joon Baek, & H.-H. Tai. (1993). Expression of two different forms of cDNA for thromboxane synthase in insect cells and site-directed mutagenesis of a critical cysteine residue. Biochemical Journal. 295(2). 457–461. 21 indexed citations
14.
Ensor, Mark & H.-H. Tai. (1992). Expression of the cDNA for NAD+-dependent 15-hydroxyprostaglandin dehydrogenase as a catalytically active enzyme in Escherichia coli. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(3). 219–222. 3 indexed citations
15.
Ichimaru, Toru & H.-H. Tai. (1992). Ateration of platelet activating factor (PAF) metabolism in rat pulmonary alveolar macrophages and plasma by cigarette smoking. Prostaglandins Leukotrienes and Essential Fatty Acids. 47(2). 123–128. 6 indexed citations
16.
Tai, H.-H., et al.. (1990). Phorbol ester induces inhibition of arachidonate incorporation into phospholipids in human neutrophilis. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(1). 51–55. 5 indexed citations
17.
Schwen, Richard J., et al.. (1990). Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Inflammation Research. 31(3-4). 329–340. 25 indexed citations
18.
Fuse, Ichiro, et al.. (1989). Phorbol ester, 1,2-diacylglycerol, and collagen induce inhibition of arachidonic acid incorporation into phospholipids in human platelets. Journal of Biological Chemistry. 264(7). 3890–3895. 70 indexed citations
19.
Shen, Rong‐Fong & H.-H. Tai. (1986). Immunoaffinity purification and characterization of thromboxane synthase from porcine lung.. Journal of Biological Chemistry. 261(25). 11592–11599. 56 indexed citations
20.
Sih, Charles J., H.-H. Tai, & Y. Y. Tsong. (1967). The Mechanism of Microbial Conversion of Cholesterol into 17-Keto Steroids. Journal of the American Chemical Society. 89(8). 1957–1958. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026